Cargando…

Learning from Cochrane systematic reviews: what improvements do these suggest for the design of trials?

Background: Many randomised trials have serious methodological flaws that fatally undermine their results, which makes the research wasteful. This is of concern for many, including those doing systematic reviews that include trials. Cochrane systematic reviews have a section called ‘  Implications f...

Descripción completa

Detalles Bibliográficos
Autores principales: Pirosca, Stefania, Clarke, Mike, Treweek, Shaun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194492/
https://www.ncbi.nlm.nih.gov/pubmed/32399204
http://dx.doi.org/10.12688/f1000research.22635.2
_version_ 1783528349239345152
author Pirosca, Stefania
Clarke, Mike
Treweek, Shaun
author_facet Pirosca, Stefania
Clarke, Mike
Treweek, Shaun
author_sort Pirosca, Stefania
collection PubMed
description Background: Many randomised trials have serious methodological flaws that fatally undermine their results, which makes the research wasteful. This is of concern for many, including those doing systematic reviews that include trials. Cochrane systematic reviews have a section called ‘  Implications for research’, which allows authors of the review to present their conclusions on how future research might be improved. Looking at these conclusions might highlight priority areas for improvement. Methods: We focused on the Cochrane Schizophrenia Review Group and the Multiple sclerosis and rare diseases of the central nervous system Review Group (the MS Review Group).  Reviews with citation dates between 2009 and 2019 were identified and the recommendations of review authors in ‘  Implications for research’ were put into categories. Results: Between 2009 and 2019 we identified 162 reviews for the Schizophrenia Review Group and 43 reviews for the MS Review Group. We created 22 categories of recommendations in total, of which 12 were common to both groups. The five most used categories were the same for both: better choice of outcomes; better choice of intervention/comparator; longer follow-up; larger sample size; use of validated scales.  Better choice of outcomes and/or intervention/comparator was recommended in over 50% of reviews. Longer follow-up and larger sample size were recommended in over a third, with use of validated scales being suggested in around a fifth of reviews. There was no obvious pattern of improvement over time for trials included in systematic reviews published by both groups. Conclusions: We suggest that trialists working in these and other areas ask themselves, or are compelled to do so by others (e.g. funders), why they have chosen their outcomes, intervention and comparator, whether follow-up is long enough, if the sample size is big enough and whether the scales they choose to measure their outcomes are appropriate.
format Online
Article
Text
id pubmed-7194492
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-71944922020-05-11 Learning from Cochrane systematic reviews: what improvements do these suggest for the design of trials? Pirosca, Stefania Clarke, Mike Treweek, Shaun F1000Res Brief Report Background: Many randomised trials have serious methodological flaws that fatally undermine their results, which makes the research wasteful. This is of concern for many, including those doing systematic reviews that include trials. Cochrane systematic reviews have a section called ‘  Implications for research’, which allows authors of the review to present their conclusions on how future research might be improved. Looking at these conclusions might highlight priority areas for improvement. Methods: We focused on the Cochrane Schizophrenia Review Group and the Multiple sclerosis and rare diseases of the central nervous system Review Group (the MS Review Group).  Reviews with citation dates between 2009 and 2019 were identified and the recommendations of review authors in ‘  Implications for research’ were put into categories. Results: Between 2009 and 2019 we identified 162 reviews for the Schizophrenia Review Group and 43 reviews for the MS Review Group. We created 22 categories of recommendations in total, of which 12 were common to both groups. The five most used categories were the same for both: better choice of outcomes; better choice of intervention/comparator; longer follow-up; larger sample size; use of validated scales.  Better choice of outcomes and/or intervention/comparator was recommended in over 50% of reviews. Longer follow-up and larger sample size were recommended in over a third, with use of validated scales being suggested in around a fifth of reviews. There was no obvious pattern of improvement over time for trials included in systematic reviews published by both groups. Conclusions: We suggest that trialists working in these and other areas ask themselves, or are compelled to do so by others (e.g. funders), why they have chosen their outcomes, intervention and comparator, whether follow-up is long enough, if the sample size is big enough and whether the scales they choose to measure their outcomes are appropriate. F1000 Research Limited 2020-06-25 /pmc/articles/PMC7194492/ /pubmed/32399204 http://dx.doi.org/10.12688/f1000research.22635.2 Text en Copyright: © 2020 Pirosca S et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Report
Pirosca, Stefania
Clarke, Mike
Treweek, Shaun
Learning from Cochrane systematic reviews: what improvements do these suggest for the design of trials?
title Learning from Cochrane systematic reviews: what improvements do these suggest for the design of trials?
title_full Learning from Cochrane systematic reviews: what improvements do these suggest for the design of trials?
title_fullStr Learning from Cochrane systematic reviews: what improvements do these suggest for the design of trials?
title_full_unstemmed Learning from Cochrane systematic reviews: what improvements do these suggest for the design of trials?
title_short Learning from Cochrane systematic reviews: what improvements do these suggest for the design of trials?
title_sort learning from cochrane systematic reviews: what improvements do these suggest for the design of trials?
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194492/
https://www.ncbi.nlm.nih.gov/pubmed/32399204
http://dx.doi.org/10.12688/f1000research.22635.2
work_keys_str_mv AT piroscastefania learningfromcochranesystematicreviewswhatimprovementsdothesesuggestforthedesignoftrials
AT clarkemike learningfromcochranesystematicreviewswhatimprovementsdothesesuggestforthedesignoftrials
AT treweekshaun learningfromcochranesystematicreviewswhatimprovementsdothesesuggestforthedesignoftrials